(Q69723270)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Treatment of metastatic malignant melanoma with recombinant interferon alpha 2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

author name string

Robinson WA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Mughal TI

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Thomas MR

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Johnson M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Spiegel RJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 September 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

3-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

275-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

The rising incidence and mortality rate of malignant melanoma

5 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980109-7

7 January 2021

Evaluation of human lymphoblastoid interferon in advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980109-7

7 January 2021

Interferons in the treatment of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980109-7

7 January 2021

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980109-7

7 January 2021

Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980109-7

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980109-7

7 January 2021

10.1016/S0171-2985(86)80109-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3804370%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference